Routine liver function monitoring is not required for patients without pre-existing liver disease, though baseline assessment may be appropriate in certain clinical situations
But people who take these drugs often experience unpleasant side effects
Revs Physiol, Biochem Pharmacol, 1983
Retatrutide usually comes up in obesity and metabolic research conversations
If diarrhea becomes severe, your provider may adjust your dose, switch formulations (injection to oral), or recommend a different GLP-1 compound like tirzepatide
Greig D, Alcaino H, Castro PF, Garcia L, Verdejo HE, Navarro M, et al